We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$585M
AUM Growth
+$56.2M
(+11%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
830
New
329
Increased
104
Reduced
143
Closed
252
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$33.9M |
| 2 |
Verizon
VZ
|
+$6.56M |
| 3 |
Lowe's Companies
LOW
|
+$6.21M |
| 4 |
Procter & Gamble
PG
|
+$6.15M |
| 5 |
Danaher
DHR
|
+$5.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$12.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 3 |
Apple
AAPL
|
+$11.1M |
| 4 |
UnitedHealth
UNH
|
+$9.36M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$6.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.76% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Healthcare | 14.64% |
| 4 | Consumer Staples | 12.4% |
| 5 | Miscellaneous | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
NovoCure
NVCR
$2.09B
| $228K | 0.04% |
+2,700
| New | +$218K |
|
|
SWCH
502
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $227K | 0.04% |
+15,305
| New | +$232K |
|
503
Realty Income
O
$58.5B
| $226K | 0.04% |
+3,170
| New | +$236K |
|
504
ProShares Ultra S&P500
SSO
$8.52B
| $226K | 0.04% |
+12,008
| New | +$207K |
|
|
AEL
505
DELISTED
American Equity Investment Life Holding Company
AEL
| $226K | 0.04% |
+7,558
| New | +$205K |
|
506
Alliant Energy
LNT
$17.7B
| $225K | 0.04% |
+4,113
| New | +$219K |
|
507
PetMed Express
PETS
$40.1M
| $224K | 0.04% |
+9,529
| New | +$213K |
|
508
Yum China
YUMC
$15.3B
| $221K | 0.04% |
4,600
-5,800
| -56% | -$258K |
|
|
HOLX
509
DELISTED
Hologic
HOLX
| $219K | 0.04% |
+4,200
| New | +$209K |
|
|
VG
510
DELISTED
Vonage Holdings Corporation
VG
| $219K | 0.04% |
29,500
-46,600
| -61% | -$403K |
|
511
El Pollo Loco
LOCO
$463M
| $218K | 0.04% |
+14,401
| New | +$201K |
|
|
AMRN
512
Amarin Corp
AMRN
$297M
| $217K | 0.04% |
505
-445
| -47% | -$169K |
|
513
Carter's
CRI
$1.22B
| $217K | 0.04% |
1,982
-406
| -17% | -$41.1K |
|
514
MDU Resources
MDU
$4.24B
| $216K | 0.04% |
+19,098
| New | +$208K |
|
515
Ormat Technologies
ORA
$6.45B
| $216K | 0.04% |
+2,900
| New | +$220K |
|
516
Pitney Bowes
PBI
$2.37B
| $214K | 0.04% |
+53,183
| New | +$244K |
|
517
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
| $214K | 0.04% |
+3,988
| New | +$205K |
|
518
Assured Guaranty
AGO
$3.34B
| $213K | 0.04% |
+4,338
| New | +$207K |
|
519
Mativ Holdings
MATV
$672M
| $213K | 0.04% |
+5,080
| New | +$211K |
|
520
Philips
PHG
$26.3B
| $213K | 0.04% |
5,497
-10,190
| -65% | -$369K |
|
521
Amgen
AMGN
$236B
| $212K | 0.04% |
+880
| New | +$194K |
|
|
VISN
522
Vistance Networks Inc
VISN
$2.68B
| $211K | 0.04% |
+14,900
| New | +$193K |
|
523
Ionis Pharmaceuticals
IONS
$10.4B
| $211K | 0.04% |
+3,485
| New | +$208K |
|
524
iShares MSCI Taiwan ETF
EWT
$11.8B
| $210K | 0.04% |
+5,100
| New | +$201K |
|
525
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
| $210K | 0.04% |
+3,600
| New | +$207K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Bayesian Capital Management held 830 positions worth $585M, up 11% from $529M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Bayesian Capital Management deployed $17.6M of net new capital in Q4 2019, opening 329 new positions and adding to 104 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $11.3M trimmed.
- Bayesian Capital Management's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
- Bayesian Capital Management added most to Edwards Lifesciences in Q4 2019, an estimated $4.47M increase.
- Bayesian Capital Management's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $11.3M.
- Bayesian Capital Management fully exited Accenture in Q4 2019, selling an estimated $12.8M.
- Bayesian Capital Management's ten largest holdings make up 17% of its $585M portfolio in Q4 2019.
- Bayesian Capital Management opened 329 new positions and closed 252 in Q4 2019.
- Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $585M.
Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.